Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.2786 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.23019 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.23054 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.13861 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.17835 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.29824 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33677 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.2069 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.18724 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.21424 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.21501 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.14779 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22518 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.22072 | 51 |